MIST · NASDAQ
Milestone Pharmaceuticals (MIST) Stock Price & Fundamentals
Milestone Pharmaceuticals (MIST) closed at $668.87 on Oct 9, 2026, down 1.60% from the previous close of $679.75.
Share price, past year
1Y +17.83%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $668.87 |
| Sep 30, 2026 | $678.38 |
| Aug 31, 2026 | $663.07 |
| Jul 31, 2026 | $667.90 |
| Jun 30, 2026 | $672.00 |
| May 29, 2026 | $704.05 |
| Apr 30, 2026 | $680.57 |
| Mar 31, 2026 | $655.56 |
| Feb 27, 2026 | $638.38 |
| Jan 30, 2026 | $605.13 |
| Dec 31, 2025 | $558.82 |
| Nov 28, 2025 | $555.41 |
| Oct 31, 2025 | $569.72 |
Key statistics
- Market cap
- $83.27B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$84.01M
- Shares outstanding
- 124.5M
- Dividend yield
- —
- 52-week range
- $551.13 – $704.62
Milestone Pharmaceuticals's market cap is $83.27B, based on a share price of $668.87 and 124.5M shares outstanding as of Jun 30, 2026.
Financials
Milestone Pharmaceuticals reported a net loss of $63.06M in fiscal 2025.
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $559.00K | −$28.61M | −$0.21 |
| Q1 FY2026ended Mar 31, 2026 | $238.00K | −$26.07M | −$0.20 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$12.97M | −$0.20 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$20.76M | −$0.31 |
Company profile
- Name
- Milestone Pharmaceuticals Inc.
- Ticker
- MIST
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1111 Boul. Dr.-Frederik-Philips, Ste 420, Montreal, A8 H4M 2X6
- Incorporated in
- A8
- Fiscal year ends
- December
- SEC CIK
- 0001408443
Recent SEC filings
- Sep 3, 2026
- Aug 12, 2026
- Aug 12, 2026
- Jun 15, 2026
- May 13, 2026
- May 13, 2026
- Mar 20, 2026
- Mar 20, 2026
Frequently asked questions
What is Milestone Pharmaceuticals's stock price?
Milestone Pharmaceuticals (MIST) closed at $668.87 on Oct 9, 2026, down 1.60% from the previous close of $679.75.
What is Milestone Pharmaceuticals's market cap?
Milestone Pharmaceuticals's market cap is $83.27B, based on a share price of $668.87 and 124.5M shares outstanding as of Jun 30, 2026.
Does Milestone Pharmaceuticals pay a dividend?
Milestone Pharmaceuticals's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Milestone Pharmaceuticals Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures